✅ Product Benefits & Highlights

• Effective gout management: Barif 40 mg Tablet is used for the chronic management of hyperuricemia in patients with gout, helping to prevent gout attacks and associated joint pain.

• Mechanism of action: Contains Febuxostat, a selective xanthine oxidase inhibitor that reduces serum uric acid levels by inhibiting the enzyme responsible for uric acid production.

• Dosage regimen: The recommended starting dose is 40 mg once daily. If serum uric acid levels are not reduced to less than 6 mg/dL after 2 weeks, the dose may be increased to 80 mg once daily.

• Minimal food interactions: Can be taken with or without food, offering flexibility in administration.

• Trusted quality: Manufactured by Square Pharmaceuticals, a leading pharmaceutical company in Bangladesh known for its commitment to quality and patient safety.